WuXi AppTec Co., Ltd. (2359.HK) stock analysis

In our weekly check, WuXi AppTec Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2.

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd. is a Healthcare company (Medical - Diagnostics & Research) based in China, listed on HKSE as 2359.HK.

What our checks show for 2359.HK

Red flags

• Analysts expect the net margin to shrink by 4.3 points from today's 40.4%.
• The stock has fallen as much as 85% from a peak. Would you have held through that?

Warning signs

• The price swings a lot: 42.6% annual volatility. Expect large ups and downs.
• Recovering from its deepest fall took about 2 years.

Strengths

• Debt is low: 0.18x equity.
• Operating profit covers interest 87.1 times over.
• The net margin rose by 18.2 points over 5 years, to 40.4%.
• The gross margin is 51.9% and has risen by 15.6 points: pricing power is holding.
• Analysts expect earnings per share to grow about 14.7% a year over the next years.
• Analysts expect revenue to grow about 20.4% a year over the next years.

Next earnings report: 2026-10-26

Similar companies

TMO · DHR · NTRA

Questions

What grade does WuXi AppTec Co., Ltd. (2359.HK) have?

In our weekly check, WuXi AppTec Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 2359.HK stock?

This week's biggest flags for WuXi AppTec Co., Ltd.: Margins expected to shrink, Deep past fall, Very volatile. In total 4 of 25 checks show a warning or a red flag.

What does WuXi AppTec Co., Ltd. do?

WuXi AppTec Co., Ltd. is a Healthcare company (Medical - Diagnostics & Research) based in China, listed on HKSE as 2359.HK.

When does WuXi AppTec Co., Ltd. report earnings next?

The next earnings report is expected on 2026-10-26. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis